Show simple item record

dc.contributor.authorSudwarts, Ari
dc.date.accessioned2017-09-28T13:37:10Z
dc.date.available2017-09-28T13:37:10Z
dc.date.issued2017-06-15
dc.date.submitted2017-09-28T13:18:35.770Z
dc.identifier.citationSudwarts, A. 2017. Zebra sh as a model for translational neurobiology: Implications for drug discovery and development. Queen Mary University of Londonen_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/25979
dc.descriptionPhDen_US
dc.description.abstractDiseases which affect the central nervous system present a huge burden to sufferers and caregivers. In tandem with longevity, prevalences of age-related neurodegenerative diseases are increasing. However, despite the evident necessity for pharmaceutical interventions, there has been a distinct lack of drug development to combat these disorders. This is largely attributed to high financial costs of using rodent models. Thus the validation of a more cost-effective in vivo system would facilitate pharmaceutical screening. The work presented in this thesis addresses this issue by assessing the utility of zebra fish in two costly areas of translational neurobiology { lead identi cation and safety pharmacology. An aversive classical conditioning assay was developed and automated as a behavioural screening method. This robust assay allows fast assessment of cognition and cognitive decline. The effect of neurotoxin treatment on aversive learning was then assessed using this assay, demonstrating its efficacy as a screening tool for neurodegeneration research. Subsequently, a transgenic zebra fish line - expressing a mutated form of the Alzheimer's-associated human amyloid precursor protein - was assessed, demonstrating an age-related cognitive impairment. Additionally new genetic zebra fish lines were generated, which over-express genes (both endogenous and transgenic) related to Alzheimer's-like pathologies. Whilst these were not assessed within this thesis, they present promising tools for possible future investigations. Regarding safety pharmacology, regulatory bodies require all CNS-penetrant drugs be assessed for abuse potential. Zebra fish display reward responses to several common drugs of abuse (e.g. amphetamine, cocaine, morphine). Thus, the latter sections of this thesis evaluated the utility of zebra fish for assessing human abuse potential. A CPP paradigm was utilised to test a range of drugs, with the sensitivity and specificity of zebra fish compared to previous reports using rodent. Additionally, the development of a zebra fish drug discrimination assay was attempted. However the paradigms utilised failed to develop an efficacious assay.en_US
dc.description.sponsorshipEPSRC and P zer Inc., grant number EP/K50290X/1en_US
dc.language.isoenen_US
dc.publisherQueen Mary University of Londonen_US
dc.rightsThe copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
dc.subjecttranslational neurobiologyen_US
dc.subjectage-related neurodegenerative diseasesen_US
dc.subjectpharmacologyen_US
dc.subjectdrug developmenten_US
dc.subjectneurodegeneration researchen_US
dc.titleZebra fish as a model for translational neurobiology: Implications for drug discovery and developmenten_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Theses [4209]
    Theses Awarded by Queen Mary University of London

Show simple item record